GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » NeoPharm Co Ltd (XKRX:092730) » Definitions » E10

NeoPharm Co (XKRX:092730) E10 : ₩2,041.69 (As of Mar. 2024)


View and export this data going back to 2007. Start your Free Trial

What is NeoPharm Co E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

NeoPharm Co's adjusted earnings per share data for the three months ended in Mar. 2024 was ₩782.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₩2,041.69 for the trailing ten years ended in Mar. 2024.

During the past 12 months, NeoPharm Co's average E10 Growth Rate was 16.30% per year. During the past 3 years, the average E10 Growth Rate was 20.80% per year. During the past 5 years, the average E10 Growth Rate was 23.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of NeoPharm Co was 26.40% per year. The lowest was 20.80% per year. And the median was 23.65% per year.

As of today (2024-05-22), NeoPharm Co's current stock price is ₩26950.00. NeoPharm Co's E10 for the quarter that ended in Mar. 2024 was ₩2,041.69. NeoPharm Co's Shiller PE Ratio of today is 13.20.

During the past 13 years, the highest Shiller PE Ratio of NeoPharm Co was 110.24. The lowest was 9.97. And the median was 29.41.


NeoPharm Co E10 Historical Data

The historical data trend for NeoPharm Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeoPharm Co E10 Chart

NeoPharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 910.32 1,126.65 1,383.99 1,663.53 1,984.57

NeoPharm Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,755.48 1,815.81 1,919.87 1,984.57 2,041.69

Competitive Comparison of NeoPharm Co's E10

For the Household & Personal Products subindustry, NeoPharm Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NeoPharm Co's Shiller PE Ratio Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, NeoPharm Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where NeoPharm Co's Shiller PE Ratio falls into.



NeoPharm Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, NeoPharm Co's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=782/118.8477*118.8477
=782.000

Current CPI (Mar. 2024) = 118.8477.

NeoPharm Co Quarterly Data

per share eps CPI Adj_EPS
201406 118.000 99.353 141.154
201409 -2.000 99.608 -2.386
201412 68.000 99.098 81.552
201503 273.000 99.720 325.365
201506 117.000 100.050 138.982
201509 179.000 100.110 212.504
201512 -88.000 100.220 -104.356
201603 424.000 100.560 501.108
201606 251.000 100.790 295.970
201609 251.000 101.460 294.015
201612 164.355 101.560 192.332
201703 474.000 102.850 547.728
201706 431.000 102.610 499.204
201709 318.000 103.490 365.191
201712 394.000 102.990 454.665
201803 602.000 104.100 687.284
201806 509.000 104.130 580.942
201809 396.000 105.650 445.468
201812 643.000 104.350 732.334
201903 662.000 104.490 752.964
201906 632.000 104.880 716.168
201909 527.000 105.200 595.368
201912 745.000 105.120 842.290
202003 689.000 105.540 775.877
202006 576.000 104.870 652.773
202009 374.000 106.200 418.541
202012 663.000 105.765 745.008
202103 726.000 107.357 803.704
202106 529.000 107.579 584.414
202109 397.000 108.759 433.826
202112 606.000 109.676 656.675
202203 630.000 111.806 669.679
202206 588.000 114.083 612.559
202209 509.000 114.831 526.803
202212 450.000 115.200 464.248
202303 871.000 116.550 888.174
202306 699.000 117.140 709.191
202309 631.000 119.111 629.604
202312 768.000 118.848 768.000
202403 782.000 118.848 782.000

Add all the adjusted EPS together and divide 10 will get our e10.


NeoPharm Co  (XKRX:092730) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

NeoPharm Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=26950.00/2041.69
=13.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of NeoPharm Co was 110.24. The lowest was 9.97. And the median was 29.41.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


NeoPharm Co E10 Related Terms

Thank you for viewing the detailed overview of NeoPharm Co's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


NeoPharm Co (XKRX:092730) Business Description

Traded in Other Exchanges
N/A
Address
928 Tamnip-dong, Yuseong-gu, Daejon, KOR, 305-510
NeoPharm Co Ltd is a South Korean company operating in the household and personal products. The products of the company include skin care brand, skin barrier special dermo cosmetic brand, hospital functional products, and life moisturizing body professional brand.

NeoPharm Co (XKRX:092730) Headlines

No Headlines